XTX Topco’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Sell
38,873
-7,498
-16% -$49.9K ﹤0.01% 2829
2026
Q1
$253K Buy
+46,371
New +$260K ﹤0.01% 2631
2025
Q4
Sell
-28,581
Closed -$221K 3785
2025
Q3
$221K Buy
+28,581
New +$223K 0.01% 1768
2025
Q2
Sell
-69,988
Closed -$557K 3154
2025
Q1
$557K Buy
+69,988
New +$708K 0.03% 949
2024
Q4
Sell
-11,030
Closed -$101K 2921
2024
Q3
$101K Sell
11,030
-10,016
-48% -$82.9K 0.01% 1605
2024
Q2
$206K Sell
21,046
-3,926
-16% -$47.9K 0.02% 1221
2024
Q1
$377K Buy
24,972
+4,308
+21% +$78.2K 0.05% 662
2023
Q4
$445K Buy
20,664
+6,558
+46% +$121K 0.1% 328
2023
Q3
$262K Sell
14,106
-13,828
-50% -$323K 0.04% 826
2023
Q2
$707K Buy
27,934
+17,804
+176% +$448K 0.13% 201
2023
Q1
$262K Buy
+10,130
New +$271K 0.06% 757
2021
Q4
Sell
-2,219
Closed -$281K 994
2021
Q3
$281K Buy
+2,219
New +$323K 0.09% 360
2021
Q2
Sell
-2,901
Closed -$527K 1087
2021
Q1
$527K Buy
+2,901
New +$673K 0.26% 81

Other funds holding TDOC

XTX Topco's TDOC Position: Q2 2026 in Review

XTX Topco reduced its Teladoc Health (TDOC) stake by 16% in Q2 2026, selling an estimated $49.9K and leaving 38,873 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

XTX Topco first reported a position in TDOC in Q1 2021 and has held it in 13 quarters since. The position peaked at $707K in Q2 2023. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • XTX Topco held 38,873 shares of Teladoc Health worth $330K as of Q2 2026.
  • XTX Topco sold 7,498 Teladoc Health shares in Q2 2026, an estimated $49.9K.
  • Teladoc Health made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2829 holding.
  • XTX Topco first reported a position in Teladoc Health in Q1 2021 and has held it in 13 quarters since.
  • XTX Topco's Teladoc Health position peaked at $707K in Q2 2023.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.